OTC · Analyst Forecast

Dr. Martens plc (DOCMF) Analyst Forecast

$1.14 OTC: DOCMF Market Cap $1.09B

Revenue and earnings estimates published by analysts covering Dr. Martens plc (DOCMF), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Dr. Martens plc, analysts forecast revenue rising from $771.65T in 2026 to $921.48T in 2031; the average estimate for 2031 earnings per share is $0.10; with published estimates ranging from $0.10 to $0.10; 5 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026$763.45T$771.65T$779.37T5
2027$773.44T$788.89T$802.78T5
2028$815.28T$825.70T$838.53T5
2029$848.79T$862.61T$876.89T2
2030$871.77T$885.96T$900.62T2
2031$906.72T$921.48T$936.73T1

Earnings per share forecast

YearLowAverageHighAnalysts
2026$0.04$0.04$0.045
2027$0.05$0.05$0.055
2028$0.06$0.06$0.065
2029$0.07$0.07$0.072
2030$0.08$0.09$0.092
2031$0.10$0.10$0.101

Dr. Martens plc (DOCMF) forecast — frequently asked questions

What are analysts forecasting for Dr. Martens plc's earnings?

The average analyst estimate for Dr. Martens plc (DOCMF) earnings per share in 2031 is 0.10, with individual estimates between 0.10 and 0.10.

How much revenue is Dr. Martens plc expected to make?

Analysts forecast Dr. Martens plc (DOCMF) revenue of $921.48T in 2031, based on 1 published estimates.

How many analysts cover DOCMF?

5 analysts contribute estimates for Dr. Martens plc (DOCMF). Thin coverage makes an average less reliable.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Consumer Cyclical StocksLow P/E Consumer Cyclical StocksHigh Net Margin Consumer Cyclical StocksDividend Consumer Cyclical StocksLow Debt Consumer Cyclical StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.